phase readout
saveNCT06998407: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Avenzo Therapeutics, Inc.. Phase: PHASE1. Conditions: HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
view source ↗
comments(0)
5-min edit window · permanent after that